Clik here to view.
Psomagen and Macrogen Granted U.S. Patent for Blockchain Data-sharing Technology
SEOUL, South Korea The precision medicine and biotechnology company Macrogen (CEO Kap-Seok Yang, www.macrogen.com) announced on September 17 that it had been granted a U.S. patent for its...
View ArticleClik here to view.
Curry Health Network Adopts ClickClean™ Advanced Laparoscopic Technology
GOLD BEACH, Ore. Curry Health Network, an integrated health care delivery system based in Gold Beach, Oregon, today announced that its flagship hospital, Curry General Hospital, has recently adopted...
View ArticleClik here to view.
HKSTP to Promote Hong Kong’s Vibrant Biotechnology and Fintech Ecosystems at...
HONG KONG Hong Kong Science and Technology Parks Corporation (HKSTP) will take part in the annual Think Asia Think Hong Kong event (TATHK), to be held on 20 September 2019 in Los Angeles, USA. TATHK...
View ArticleClik here to view.
Riverain Receives $15 Million Growth Capital Investment
MIAMISBURG, Ohio Riverain Technologies, a leading provider of clinical artificial intelligence software used to efficiently detect lung disease at its earliest stages, has received a $15 million...
View ArticleClik here to view.
Shiseido Marks the 30th Anniversary of Joint Research in Dermatology
TOKYO Shiseido Company, Limited (“Shiseido”) has agreed on Tuesday, September 17, 2019 to extend for a further six years its research alliance with the dermatological laboratory CBRC (Cutaneous...
View ArticleClik here to view.
Ironwood Pharmaceuticals and AstraZeneca Amend LINZESS® (linaclotide)...
CAMBRIDGE, Mass. Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI healthcare company, announced today that it has amended its collaboration agreement with AstraZeneca for the development and...
View ArticleClik here to view.
Clik here to view.
Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th...
LYON, France POXEL S.A. (Euronext – POXEL – FR0012432516), a biopharmaceutical company dedicated to the development of innovative treatments for metabolic disorders, including type 2 diabetes and...
View ArticleClik here to view.
Daon宣布John Sanders担任新兴市场总裁
弗吉尼亚州雷斯顿 (美国商业资讯)–全球生物识别技术领军Daon今天宣布，John Sanders已加入公司领导团队，担任新兴市场总裁。Sanders将负责Daon行业领先的识别平台在全球的市场拓展。...
View ArticleClik here to view.
CDISC Publishes First Standard Using Traditional Chinese Medicine
AUSTIN, Texas CDISC is pleased to announce the first release of a global Therapeutic Area Standard using Traditional Chinese Medicine. Specifically, the standard describes how to use CDISC standards...
View ArticleClik here to view.
CORRECTING and REPLACING CDISC Publishes First Standard Using Traditional...
AUSTIN, Texas Please replace the release with the following corrected version due to multiple revisions in the third paragraph. The corrected release reads: CDISC PUBLISHES FIRST STANDARD USING...
View ArticleClik here to view.
Takeda Recognized in the 2019 Dow Jones Sustainability World Index
OSAKA, Japan Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502/NYSE:TAK) today announced that it has been named in the 2019 Dow Jones Sustainability World Index, achieving more than...
View ArticleClik here to view.
武田薬品：社会的責任投資指数「2019 Dow Jones Sustainability World Index」に選出
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社は、このたび、社会的責任投資の代表的指数の一つである「2019 Dow Jones Sustainability World Index」の対象銘柄に初めて選出されるとともに、10年連続で「Dow Jones Sustainability Asia Pacific...
View ArticleClik here to view.
资生堂庆贺皮肤科合作研究30周年
东京 (美国商业资讯)–株式会社资生堂（Shiseido Company, Limited，“资生堂”）于2019年9月17日（周二）同意延长与皮肤科实验室CBRC（皮肤生物学研究中心）的合作研究，为期六年，CBRC由哈佛医学院皮肤科研究实验室和麻省综合医院在美国麻省波士顿设立。这份新协议将于2021年7月生效直至2027年6月。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
SanBio Granted Regenerative Medicine Advanced Therapy Designation from the...
MOUNTAIN VIEW, Calif. The SanBio Group (SanBio Co., Ltd. and SanBio, Inc.)(TOKYO:4592), a scientific leader in regenerative medicine for neurological disorders, today announced that the U.S. Food...
View ArticleClik here to view.
デオンがジョン・サンダースを新興市場担当プレジデントに任命したと発表
米バージニア州レストン (ビジネスワイヤ) — 生体認証技術の世界的リーダー企業であるデオンは本日、ジョン・サンダースが新興市場担当プレジデントとして当社経営陣に加わったと発表しました。サンダースは、業界をリードするデオンの本人確認プラットフォーム技術を世界市場に拡大していく活動の指揮を執ります。...
View ArticleClik here to view.
盟科医药宣布新型抗菌药康泰唑胺（Contezolid）针对复杂性皮肤及软组织感染的中国三期临床试验获得积极结果
上海，中国和福斯特城，加州，美国 (美国商业资讯)– 盟科医药今天宣布，其首个抗菌新药康泰唑胺（contezolid，又名MRX-I)，在中国开展的一项治疗复杂性皮肤及软组织感染（cSSTI）的关键性三期临床试验获得积极结果。康泰唑胺在主要终点治愈检验期（TOC，最后一次给药后的7-14天）的临床治愈率，非劣效于利奈唑胺，并显示了更低的药物相关的血液学不良事件。...
View ArticleClik here to view.
MicuRx Reports Positive Top-line Results of a China Phase 3 Clinical Trial...
SHANGHAI & FOSTER CITY, Calif. MicuRx Pharmaceuticals, Inc., today announced positive top-line results from the pivotal Phase 3 clinical trial in China for its lead antibacterial drug candidate...
View ArticleClik here to view.
Fusionex and IMU Introduce Big Data Analytics to Accelerate Medical Education...
KUALA LUMPUR, Malaysia Multi-award-winning data technology provider, Fusionex, and Malaysia’s pioneer private medical and health sciences university, the International Medical University (IMU) are...
View ArticleClik here to view.
Solasia宣布，Darinaparsin治疗T细胞淋巴瘤2期枢纽性研究患者登记达到目标病例数
东京 (美国商业资讯)–Solasia Pharma K.K.（TSE:4597，总部：东京，总裁兼首席执行官：Yoshihiro Arai，以下简称“Solasia”）是一家总部位于亚洲的专科制药公司。该公司今天宣布，darinaparsin 2期研究患者登记达到目标病例数。...
View Article